Dana-Farber Cancer Institute CEO Wants To Tax Biopharma To Pay For The NIH
We are all sympathetic with getting significantly more funding for the NIH. After all, this can benefit us all. Let ’s do so in a more creative fashion than levying a “tax”. Let’s try to find a win-win solution that we can all embrace.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: NYSE:PFE NASDAQ:AAPL NYSE:MRK Source Type: news